{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0006-5374#drug","name":"SEGLUROMET","alternateName":"ertugliflozin and metformin hydrochloride","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0006-5374"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA209806"},{"@type":"PropertyValue","propertyID":"UNII","value":"786Z46389E|MLU731K321"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"a6aeb99a-ce49-4125-90ce-642df3f1ebad"}],"activeIngredient":"ERTUGLIFLOZIN PIDOLATE, METFORMIN HYDROCHLORIDE","administrationRoute":["ORAL"],"dosageForm":"TABLET, FILM COATED","manufacturer":{"@type":"Organization","name":"Merck Sharp & Dohme LLC"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA209806","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6aeb99a-ce49-4125-90ce-642df3f1ebad","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-5374"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T17:24:38.510Z"}}